Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE22.3700
- TODAY'S CHANGE (%)-0.2700 (-1.1926%)
- Bid / Lots20.5000/ 2
- Ask / Lots24.5000/ 5
- Open / Previous Close22.7400 / 22.6400
- Day Range
- 52 Week Range
- Volume729,264
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 10354 | 22.7031 |
| 09:33 ET | 500 | 22.55 |
| 09:35 ET | 1186 | 22.6 |
| 09:37 ET | 417 | 22.62 |
| 09:39 ET | 400 | 22.48 |
| 09:42 ET | 2018 | 22.635 |
| 09:44 ET | 2685 | 22.51 |
| 09:46 ET | 1348 | 22.62 |
| 09:48 ET | 21029 | 22.61 |
| 09:50 ET | 100 | 22.57 |
| 09:51 ET | 2199 | 22.76 |
| 09:53 ET | 800 | 22.82 |
| 09:55 ET | 800 | 22.655 |
| 09:57 ET | 100 | 22.625 |
| 10:00 ET | 14370 | 22.61 |
| 10:02 ET | 4330 | 22.565 |
| 10:04 ET | 8108 | 22.505 |
| 10:06 ET | 915 | 22.48 |
| 10:08 ET | 6960 | 22.22 |
| 10:09 ET | 3750 | 22.235 |
| 10:11 ET | 600 | 22.27 |
| 10:13 ET | 1314 | 22.464 |
| 10:15 ET | 500 | 22.55 |
| 10:18 ET | 800 | 22.68 |
| 10:20 ET | 16654 | 22.704 |
| 10:22 ET | 1000 | 22.605 |
| 10:24 ET | 500 | 22.7 |
| 10:26 ET | 3000 | 22.61 |
| 10:27 ET | 1444 | 22.62 |
| 10:29 ET | 700 | 22.6 |
| 10:31 ET | 800 | 22.544 |
| 10:33 ET | 1799 | 22.47 |
| 10:36 ET | 1151 | 22.56 |
| 10:38 ET | 3068 | 22.66 |
| 10:40 ET | 600 | 22.73 |
| 10:42 ET | 2300 | 22.595 |
| 10:44 ET | 1632 | 22.64 |
| 10:45 ET | 622 | 22.61 |
| 10:47 ET | 3759 | 22.56 |
| 10:49 ET | 500 | 22.59 |
| 10:51 ET | 300 | 22.7 |
| 10:54 ET | 5436 | 22.7 |
| 10:56 ET | 1785 | 22.675 |
| 10:58 ET | 500 | 22.79 |
| 11:00 ET | 558 | 22.78 |
| 11:02 ET | 800 | 22.755 |
| 11:03 ET | 15910 | 22.62 |
| 11:05 ET | 400 | 22.66 |
| 11:07 ET | 1162 | 22.66 |
| 11:09 ET | 500 | 22.61 |
| 11:12 ET | 300 | 22.67 |
| 11:14 ET | 900 | 22.7 |
| 11:16 ET | 1000 | 22.73 |
| 11:18 ET | 815 | 22.78 |
| 11:20 ET | 400 | 22.79 |
| 11:21 ET | 1200 | 22.725 |
| 11:23 ET | 1000 | 22.69 |
| 11:25 ET | 879 | 22.795 |
| 11:27 ET | 800 | 22.84 |
| 11:30 ET | 1008 | 22.83 |
| 11:32 ET | 600 | 22.82 |
| 11:34 ET | 300 | 22.78 |
| 11:36 ET | 2844 | 22.82 |
| 11:38 ET | 1624 | 22.745 |
| 11:39 ET | 1000 | 22.814 |
| 11:41 ET | 300 | 22.73 |
| 11:43 ET | 410 | 22.68 |
| 11:45 ET | 100 | 22.735 |
| 11:48 ET | 670 | 22.74 |
| 11:50 ET | 1016 | 22.745 |
| 11:52 ET | 700 | 22.755 |
| 11:54 ET | 1372 | 22.7749 |
| 11:56 ET | 2367 | 22.86 |
| 11:57 ET | 431 | 22.88 |
| 11:59 ET | 300 | 22.92 |
| 12:01 ET | 916 | 22.86 |
| 12:03 ET | 2289 | 22.82 |
| 12:06 ET | 600 | 22.8 |
| 12:08 ET | 2240 | 22.75 |
| 12:10 ET | 400 | 22.86 |
| 12:12 ET | 411 | 22.845 |
| 12:14 ET | 500 | 22.88 |
| 12:15 ET | 300 | 22.89 |
| 12:17 ET | 500 | 22.875 |
| 12:19 ET | 500 | 22.89 |
| 12:21 ET | 400 | 22.935 |
| 12:24 ET | 400 | 22.87 |
| 12:26 ET | 400 | 22.894 |
| 12:28 ET | 950 | 22.9064 |
| 12:30 ET | 400 | 22.885 |
| 12:32 ET | 316 | 22.94 |
| 12:33 ET | 600 | 22.974 |
| 12:35 ET | 300 | 22.94 |
| 12:37 ET | 700 | 22.93 |
| 12:39 ET | 650 | 22.96 |
| 12:42 ET | 100 | 22.95 |
| 12:44 ET | 533 | 22.965 |
| 12:46 ET | 1230 | 23.02 |
| 12:48 ET | 570 | 23.06 |
| 12:50 ET | 500 | 23.04 |
| 12:51 ET | 810 | 23.074 |
| 12:53 ET | 1200 | 23.04 |
| 12:55 ET | 100 | 23.05 |
| 12:57 ET | 600 | 23.084 |
| 01:00 ET | 400 | 23.07 |
| 01:02 ET | 1419 | 23.01 |
| 01:04 ET | 500 | 23.044 |
| 01:06 ET | 500 | 23 |
| 01:08 ET | 500 | 22.965 |
| 01:09 ET | 900 | 22.975 |
| 01:11 ET | 3107 | 22.98 |
| 01:13 ET | 1351 | 23.05 |
| 01:15 ET | 1000 | 23.074 |
| 01:18 ET | 500 | 22.99 |
| 01:20 ET | 300 | 22.99 |
| 01:22 ET | 200 | 22.995 |
| 01:24 ET | 695 | 22.97 |
| 01:26 ET | 2300 | 22.98 |
| 01:27 ET | 1139 | 22.95 |
| 01:29 ET | 600 | 22.91 |
| 01:31 ET | 500 | 22.94 |
| 01:33 ET | 800 | 22.895 |
| 01:36 ET | 942 | 22.88 |
| 01:38 ET | 900 | 22.9 |
| 01:40 ET | 2133 | 22.915 |
| 01:42 ET | 1120 | 22.865 |
| 01:44 ET | 900 | 22.92 |
| 01:45 ET | 314 | 23 |
| 01:47 ET | 1863 | 22.9 |
| 01:49 ET | 502 | 22.96 |
| 01:51 ET | 300 | 22.96 |
| 01:54 ET | 1806 | 22.874 |
| 01:56 ET | 600 | 22.864 |
| 01:58 ET | 1447 | 22.837773 |
| 02:00 ET | 600 | 22.83 |
| 02:02 ET | 640 | 22.78 |
| 02:03 ET | 300 | 22.73 |
| 02:05 ET | 200 | 22.76 |
| 02:07 ET | 1271 | 22.754 |
| 02:09 ET | 200 | 22.67 |
| 02:12 ET | 300 | 22.62 |
| 02:14 ET | 300 | 22.68 |
| 02:16 ET | 2143 | 22.64 |
| 02:18 ET | 800 | 22.68 |
| 02:20 ET | 1100 | 22.62 |
| 02:21 ET | 600 | 22.68 |
| 02:25 ET | 400 | 22.744 |
| 02:27 ET | 200 | 22.73 |
| 02:30 ET | 3361 | 22.815 |
| 02:32 ET | 100 | 22.864 |
| 02:34 ET | 2285 | 22.78 |
| 02:36 ET | 100 | 22.83 |
| 02:38 ET | 700 | 22.77 |
| 02:39 ET | 900 | 22.78 |
| 02:41 ET | 200 | 22.765 |
| 02:43 ET | 500 | 22.76 |
| 02:45 ET | 9786 | 22.74 |
| 02:48 ET | 1200 | 22.755 |
| 02:50 ET | 2583 | 22.77 |
| 02:52 ET | 900 | 22.76 |
| 02:54 ET | 300 | 22.78 |
| 02:56 ET | 5500 | 22.81 |
| 02:57 ET | 9499 | 22.81 |
| 02:59 ET | 300 | 22.77 |
| 03:01 ET | 2100 | 22.745 |
| 03:03 ET | 700 | 22.74 |
| 03:06 ET | 11259 | 22.68 |
| 03:08 ET | 511 | 22.71 |
| 03:10 ET | 200 | 22.8 |
| 03:12 ET | 100 | 22.76 |
| 03:14 ET | 500 | 22.76 |
| 03:15 ET | 1186 | 22.72 |
| 03:17 ET | 906 | 22.72 |
| 03:19 ET | 3693 | 22.78 |
| 03:21 ET | 704 | 22.78 |
| 03:24 ET | 1300 | 22.82 |
| 03:26 ET | 700 | 22.85 |
| 03:28 ET | 2432 | 22.79 |
| 03:30 ET | 1100 | 22.81 |
| 03:32 ET | 300 | 22.79 |
| 03:33 ET | 800 | 22.785 |
| 03:35 ET | 1739 | 22.8 |
| 03:37 ET | 3170 | 22.8 |
| 03:39 ET | 117619 | 22.74 |
| 03:42 ET | 7323 | 22.56 |
| 03:44 ET | 13891 | 22.62 |
| 03:46 ET | 1100 | 22.62 |
| 03:48 ET | 1353 | 22.68 |
| 03:50 ET | 1187 | 22.65 |
| 03:51 ET | 1769 | 22.645 |
| 03:53 ET | 2257 | 22.62 |
| 03:55 ET | 5102 | 22.6 |
| 03:57 ET | 9469 | 22.47 |
| 04:00 ET | 111921 | 22.37 |
Nov 20, 2024
Nov 17, 2024
Nov 15, 2024
DJ Nurix Therapeutics Down Over 10%, on Pace for Largest Percent Decrease Since October 2023 -- Data Talk, from 1:52PM ET on Friday Nov 15, 2024 by Dow Jones
1:52PM ET on Friday Nov 15, 2024 by Dow Jones
Nov 6, 2024
DJ Nurix Therapeutics Price Target Maintained With a $29.00/Share by Needham, from 6:19AM ET on Wednesday Nov 06, 2024 by Dow Jones
6:19AM ET on Wednesday Nov 06, 2024 by Dow Jones
Nov 5, 2024
Nurix Therapeutics Announces Presentations at the 66th American Society of Hematology (ASH) Annual Meeting, from 9:01AM ET on Tuesday Nov 05, 2024 by Dow Jones
9:01AM ET on Tuesday Nov 05, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.6B | -7.7x | --- |
Arvinas Inc | 1.6B | -5.2x | --- |
Recursion Pharmaceuticals Inc | 1.7B | -3.8x | --- |
Travere Therapeutics Inc | 1.5B | -4.0x | --- |
Viridian Therapeutics Inc | 1.6B | -4.6x | --- |
Neumora Therapeutics Inc | 1.6B | -5.5x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.6B |
|---|---|
Revenue (TTM) | $56.4M |
Shares Outstanding | 70.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.17 |
EPS | $-2.91 |
Book Value | $4.12 |
P/E Ratio | -7.7x |
Price/Sales (TTM) | 28.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -343.30% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
